Dietmar Berger insider trades

Open-market stock purchases and sales by Dietmar Berger, Chief Medical Officer at Gilead Sciences, Inc, from SEC Form 4 filings since May 7, 2018.

Recent trades

DateStockTradeValue
Sep 10, 2026GILD Gilead Sciences, IncSold (not open market)$38.1K
Sep 10, 2026GILD Gilead Sciences, IncBought (not open market)—
Jun 10, 2026GILD Gilead Sciences, IncSold (not open market)$31.9K
Jun 10, 2026GILD Gilead Sciences, IncBought (not open market)—
Mar 10, 2026GILD Gilead Sciences, IncSold (not open market)$158K
Mar 10, 2026GILD Gilead Sciences, IncBought (not open market)—
Mar 10, 2026GILD Gilead Sciences, IncBought (not open market)—
Mar 10, 2026GILD Gilead Sciences, IncBought (not open market)—
Feb 27, 2026GILD Gilead Sciences, IncBought (not open market)—
Jan 2, 2026GILD Gilead Sciences, IncBought (not open market)—
Jan 2, 2026GILD Gilead Sciences, IncSold (not open market)$844K

Companies traded

  • GILD Gilead Sciences, Inc: other filings, last Sep 10, 2026
  • ATRA Atara Biotherapeutics, Inc: other filings, last May 7, 2019

Get free alerts when Dietmar Berger files a new trade →